Titanium-based implants are widely used in orthopedic and trauma surgery; however, postoperative infections remain a major cause of implant failure due to early bacterial adhesion. Localized antibiotic delivery from surface coatings offers a promising strategy to prevent initial colonization during the critical postoperative period. In this study, a self-organized TiO2 nanotubular oxide layer was fabricated on Ti-407 by electrochemical anodization in a glycerol/NH4F electrolyte at 40–60 V. SEM revealed vertically aligned single-walled nanotubes with diameters and lengths of ~80 nm and ~10 µm respectively. XPS analysis verified TiO2 formation with Al–O, V–O, and fluorine incorporation. Ceftriaxone was successfully loaded into the nanotubular structure, as identified by FT-IR. UV–Vis measurements showed a biphasic release profile consisting of an initial burst followed by sustained release determined by nanotube geometry. In vitro antibacterial activity was evaluated against Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli using optical density, CFU quantification, and an agar diffusion assay. Unloaded surfaces showed no inhibition, whereas ceftriaxone-loaded nanotubes significantly reduced bacterial growth up to ~6% and generated clear inhibition zones. These findings demonstrate, for the first time, that TiO2 nanotubular coatings derived from Ti-407 support drug loading and demonstrate effective in vitro antibacterial activity, highlighting their potential for infection-resistant orthopedic implants.
Melendez-Anzures et al. (Thu,) studied this question.